» Articles » PMID: 34568310

Imaging of α-Synuclein Aggregates in a Rat Model of Parkinson's Disease Using Raman Microspectroscopy

Overview
Specialty Cell Biology
Date 2021 Sep 27
PMID 34568310
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A hallmark of Parkinson's disease (PD) is the formation of Lewy bodies in the brain. Lewy bodies are rich in the aggregated form of misfolded α-Synuclein (α-Syn). The brain from PD patients can only be analyzed after postmortem, therefore, limiting the diagnosis of PD to the manifestation of motor symptoms. In PD patients and animal models, phosphorylated α-Syn was detected in the peripheral tissues including the gut, thus, raising the hypothesis that early-stage PD could be diagnosed based on colon tissue biopsies. Non-invasive marker-free technologies represent ideal methods to potentially detect aggregated α-Syn . Raman microspectroscopy has been established for the detection of molecular changes such as alterations of protein structures. Using Raman imaging and microspectroscopy, we analyzed the olfactory bulb in the brain and the muscularis mucosae of colon tissue sections of a human BAC-SNCA transgenic (TG) rat model. Raman images from TG and WT rats were investigated using principal component analysis (PCA) and true component analysis (TCA). Spectral components indicated protein aggregates (spheroidal oligomers) in the TG rat brain and in the colon tissues even at a young age but not in WT. In summary, we have demonstrated that Raman imaging is capable of detecting α-Syn aggregates in colon tissues of a PD rat model and making it a promising tool for future use in PD pathology.

Citing Articles

Molecular Insights into α-Synuclein Fibrillation: A Raman Spectroscopy and Machine Learning Approach.

Coles N, Elsheikh S, Quesnel A, Butler L, Jennings C, Tarzi C ACS Chem Neurosci. 2025; 16(4):687-698.

PMID: 39875340 PMC: 11843597. DOI: 10.1021/acschemneuro.4c00726.


Applications of Raman spectroscopy in the diagnosis and monitoring of neurodegenerative diseases.

Chen C, Qi J, Li Y, Li D, Wu L, Li R Front Neurosci. 2024; 18:1301107.

PMID: 38370434 PMC: 10869569. DOI: 10.3389/fnins.2024.1301107.


From Research to Diagnostic Application of Raman Spectroscopy in Neurosciences: Past and Perspectives.

Klamminger G, Frauenknecht K, Mittelbronn M, Kleine Borgmann F Free Neuropathol. 2023; 3.

PMID: 37284145 PMC: 10209863. DOI: 10.17879/freeneuropathology-2022-4210.


Raman Spectroscopy as a Tool to Study the Pathophysiology of Brain Diseases.

Terrones O, Olazar-Intxausti J, Anso I, Lorizate M, Nieto-Garai J, Contreras F Int J Mol Sci. 2023; 24(3).

PMID: 36768712 PMC: 9917237. DOI: 10.3390/ijms24032384.


Raman Spectroscopy on Brain Disorders: Transition from Fundamental Research to Clinical Applications.

Ranasinghe J, Wang Z, Huang S Biosensors (Basel). 2023; 13(1).

PMID: 36671862 PMC: 9855372. DOI: 10.3390/bios13010027.


References
1.
Bengoa-Vergniory N, Roberts R, Wade-Martins R, Alegre-Abarrategui J . Alpha-synuclein oligomers: a new hope. Acta Neuropathol. 2017; 134(6):819-838. PMC: 5663814. DOI: 10.1007/s00401-017-1755-1. View

2.
Bridi J, Hirth F . Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease. Front Neurosci. 2018; 12:80. PMC: 5825910. DOI: 10.3389/fnins.2018.00080. View

3.
Stevenson T, Murray H, Turner C, Faull R, Dieriks B, Curtis M . α-synuclein inclusions are abundant in non-neuronal cells in the anterior olfactory nucleus of the Parkinson's disease olfactory bulb. Sci Rep. 2020; 10(1):6682. PMC: 7174302. DOI: 10.1038/s41598-020-63412-x. View

4.
Chandra R, Hiniker A, Kuo Y, Nussbaum R, Liddle R . α-Synuclein in gut endocrine cells and its implications for Parkinson's disease. JCI Insight. 2017; 2(12). PMC: 5470880. DOI: 10.1172/jci.insight.92295. View

5.
Liddle R . Parkinson's disease from the gut. Brain Res. 2018; 1693(Pt B):201-206. PMC: 6003841. DOI: 10.1016/j.brainres.2018.01.010. View